SCHEMBL901984

SCHEMBL901984

FC(F)(F)c1ccnc(Nc2nc(Br)cc3ccccc23)c1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IDH2 P48735 1/20 0.42
RIOK2 Q9BVS4 1/20 0.42
TAS2R14 Q9NYV8 1/20 0.42
CNR2 P34972 2/20 0.40
SYK P43405 3/20 0.40
NOS3 P29474 1/20 0.39
NOS2 P35228 1/20 0.39
ABCG2 Q9UNQ0 1/20 0.38
AURKA O14965 2/20 0.38
MAPK1 P28482 1/20 0.38
TEAD1 P28347 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PHGDH O43175 1/20 0.37
KARS1 Q15046 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1704286 0.76 KDR (0.39) ALDH1A1
SCHEMBL15829252 0.74 SYK (0.49) IDH2TAS2R14SYKNOS3NOS2
SCHEMBL1704454 0.74 KARS1 (0.50) IDH2RIOK2TAS2R14SYKNOS3
SCHEMBL1704065 0.73 KARS1 (0.48) IDH2RIOK2SYKABCG2AURKA
SCHEMBL13726067 0.72 SYK (0.62) IDH2SYK
SCHEMBL13737619 0.72 NOS3 (0.49) IDH2SYKNOS3NOS2MAPK1
SCHEMBL17443159 0.72 IDH2 (0.45) IDH2RIOK2TAS2R14SYKNOS3
SCHEMBL16876450 0.71 TAS2R14 (0.51) IDH2RIOK2TAS2R14SYKNOS3
SCHEMBL15819732 0.70 SYK (0.46) IDH2RIOK2SYKNOS3NOS2
SCHEMBL17536757 0.69 SYK (0.45) IDH2SYKNOS3NOS2AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2441755-A1 Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors Almirall, S.A. (ES) 2012-04-18 EP disclosed
WO-2012041476-A1 PYRIDINE AND ISOQUINOLINE DERIVATIVES AS SYK- AND JAK-KINASE INHIBITORS ALMIRALL, S.A. (ES) 2012-04-05 WO disclosed